The share price of JMI Syringes & Medical Devices is soaring without having any undisclosed price sensitive information.
Within a week, the company’s share price jumped more than 28 per cent or Tk 55 each to close at Tk 255.20 on December 13. Its share price was Tk 201 a week ago on December 05.
The company’s share traded between Tk 67.10 and Tk 270.50 each in the last one year.
Following the ‘abnormal’ price hike, the Dhaka Stock Exchange (DSE) served show-cause notice on the company on December 13.
The company, however, informed the DSE that there was no undisclosed price sensitive information for ‘unusual’ price hike of its shares.
The company has also requested the investors not to consider any rumors related to the company and take their investment decisions prudently.
JMI Syringes, which was listed on the Dhaka bourse in 2013, recommended 30 per cent cash dividend for the year ended on June 30, 2018.
In 2017, the company also paid 30 per cent cash dividend.
The company’s earnings per share (EPS) was Tk 1.00 for July-September 2018 as against Tk 0.78 for July-September 2017.
The net operating cash flow per share (NOCFPS) was Tk 5.00 for July-September 2018 as against negative Tk 3.91 for July-September 2017.
The net asset value (NAV) per share was Tk 72.22 as on September 30, 2018 and Tk 68.39 as on September 30, 2017.
The company’s paid-up capital is Tk 110 million and authorised capital is Tk 1.0 billion, while the total number of securities is 11 million.
The sponsor-directors own 49.31 per cent stake in the company while the institutional investors own 14.63 per cent, foreign investors11.82 per cent and the general public 24.24 per cent as on November 30, 2018, the DSE data shows.
